AstraZeneca agrees to research deal worth up to $5.22 billion with CSPC

Mihaela Păun

AstraZeneca said on Friday it has agreed to a research deal with Chinese drugmaker CSPC Pharmaceuticals worth up to $5.22 billion to focus on AI-enabled initiatives.

din zilele anterioare

What To Know About Trump’s Military Parade http://time.com - 12.06.2025 19:04